Dotmatics Teams with Leading Distributor to Launch Life Science Informatics Platform in China
News Mar 05, 2013
“Our integrated enterprise informatics systems are already in use by several key research organizations in China and we are very excited at the opportunities opened up by our partnership with Shanghai Budou Technology,” says Bill Bailey, Global Head of Sales at Dotmatics. “Shanghai Budou Technology brings the energy, enthusiasm and experience we need to deliver our web-based informatics into this technology hungry region. They will also help us to provide an extra level of service and support to all our customers in China.”
Dotmatics delivers integrated enterprise informatics systems that improve access to data and promote collaboration. The Dotmatics range includes: the electronic lab notebook Studies Notebook; data query, reporting and visualization tools; compound, sample and inventory data management solutions; registration systems; secure document management. These can be deployed via in-house servers or using Dotmatics’ rapid deployment cloud technology to allow the secure exchange of information within an organization, between global sites and with external partners.
Kevin Qin, General Manager of Shanghai Budou Technology says, “We are delighted to be appointed as distributors of the Dotmatics Platform in China. Their comprehensive and powerful informatics solutions add real value to life science research, enabling scientists to manage and exploit the large quantities of valuable data produced at every stage of discovery research. As a distributor of Dotmatics software solutions, Shanghai Budou Technology will supply technical support, training and services that will meet the needs of their local customers.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE